XML 18 R8.htm IDEA: XBRL DOCUMENT
v3.22.1

Net Income (Loss) Per Share | 3 Months Ended
--- | ---
Mar. 31, 2022
Earnings Per Share [Abstract] |
Net Income (Loss) Per Share | Note 2. Net Income (Loss) Per Share The following table summarizes the computation of basic and diluted net loss (income) per share attributable to common stockholders of the Company:
|  | Three Months Ended March 31, |
|  | 2022 |  |  | 2021 |
|  | (in thousands, except per share data) |
Net income (loss) attributable to common stockholders |  | $ | 6,140 |  |  | $ | (3,565 | )
Weighted-average shares outstanding |  |  |  |  |  |
Weighted average shares used to compute basic net income (loss) per share |  |  | 20,921 |  |  |  | 17,868 |
Dilutive effect of employee equity incentive plans |  |  | 1,782 |  |  |  | — |
Weighted average shares used to compute diluted net income (loss) per share |  |  | 22,703 |  |  |  | 17,868 |
Net income (loss) attributable to common stockholders per share, basic |  | $ | 0.29 |  |  | $ | (0.20 | )
Net income (loss) attributable to common stockholders per share, diluted |  | $ | 0.27 |  |  | $ | (0.20 | )
Potential dilutive securities include dilutive common shares from share-based awards attributable to the assumed exercise of restricted stock unit awards using the treasury stock method. Under the treasury stock method, potential common shares outstanding are not included in the computation of diluted net income per share if their effect is anti-dilutive. Anti-dilutive potential shares from share-based awards are excluded from the calculation of diluted earnings per share if either their exercise price exceeded the average market price during the period or the share-based awards were determined to be anti-dilutive based on applying the treasury stock method. During the three months ended March 31, 2022 and 2021, the Company had 3,211 potential shares and 2,201,903 potential shares from share-based awards that are anti-dilutive, respectively. Anti-dilutive potential shares from share-based awards are excluded from the calculation of diluted loss per share for the three months ended March 31, 2021 due to the net loss reported in this period.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -URI http://asc.fasb.org/topic&trid=2144383 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration